Saturday, Apr 20 2024 | Time 04:40 Hrs(IST)
image
Business EconomyPosted at: Apr 16 2021 8:23PM


Shatplus, a ray of hope for healthy body and improved immunity

Pune, Apr 16 (UNI) Bharat Vikas Group (BVG), Life Sciences Limited, a next generation health and wellness company, aims to develop eco-friendly Sat innovative evidence based herbals and phytopharmaceuticals for better healthcare, a release said on Friday.
Traditional knowledge and Ayurveda based medicines with scientific validations are the need of current drug discovery community.
With years of rigorous R&D, BVG has come up with ‘ShatPlus, a blend of Ayurveda-based knowledge and Modern science techniques specifically designed to strengthen the immune system and fight against various viral and bacterial infections, release told.
During the research studies, it was observed that ShatPlus is completely safe for uses, have anti-oxidative, anti-inflammatory, anti-viral and immunomodulatory properties.
Addressing the crowded press conference here today, H R Gaikwad, Chairman and managing director of BVG here today said with the emergence of COVID-19 pandemic in 2019-2020 BVG focused its research on COVID-19 management and established positive outcomes for ShatPlus. ShatPlus showed more than 94 percent reduction in the SARS-CoV Viral Load in laboratory tests.
A CTRI registered clinical trial of ShatPlus was conducted on COVID-19 patients (n=60) at Dr. Naidu Infectious Diseases Hospital, he apprised.

It was concluded that ShatPlus as adjuvant therapy showed rapid recovery of COVID-19 patients. Within 4th Day of treatment 73.3%, 7th Day of treatment 96.7% and 10th Day 100% patients recovered in ShatPlus Treatment Group.
ShatPlus treatment showed positive effects on the indicators of immunity in comparison to Standard Treatment group, he added.

ShatPlus treatment also improved other symptoms such as cough, breathlessness etc. and was found to be 100% safe without any adverse effects.
ShatPlus is a clinically validated ayurvedic proprietary medicine that seems to prevent and fights against viral infections.
In current pandemic of COVID-19 which is spreading at a rapid rate, the role of body’s defense system is very crucial and is the need of hour. ShatPlus can play vital role in the prevention and protection against contagious diseases as an Adjuvant therapy, told Mr Gaikwad.
He further said that the vision of BVG is to provide effective and quality products to the global society in the service of mankind.
He also emphasized to explore and develop healthcare solutions based on established and proven traditional ayurvedic knowledge systems.
Dr. Pawan K Singh, Vice President BVG Life Sciences said that the aim of BVG is to develop innovative herbal health products which are based on ayurvedic concepts and fortified with modern scientific techniques.
UNI SP KAZ SHK2031
Please log in to get detailed story.
Tags: #Shatplus# a ray of hope for healthy body and improved immunity
More News

"CSIR-IICT and BHEL partners to advance clean fuel technology: MoU signed on CO2 to DME"

19 Apr 2024 | 7:23 PM

Hyderabad, April 19 (UNI) The Council of Scientific and Industrial Research-Indian Institute of Chemical Technology (CSIR-IICT) and Bharat Heavy Electricals Limited (BHEL) Corporate R&D have forged a partnership to develop technology for capturing and converting carbon dioxide (CO2) to Dimethyl Ether (DME) through direct catalytic conversion.

see more..

Amara Raja Infra Wins Greenko’s 700MWp solar project in AP

19 Apr 2024 | 6:41 PM

Hyderabad, Apr 19 (UNI) Amara Raja Infra Private Limited (ARIPL), part of the $1.75 billion Amara Raja Group, on Friday announced it has secured a solar BoS (Balance of System) project of 500MW/700MWp from Greenko.

see more..
Sensex recovers 600 points on heavy buying on last day of week

Sensex recovers 600 points on heavy buying on last day of week

19 Apr 2024 | 5:34 PM

Mumbai, April 19 (UNI) Snapping a losing streak of last four sessions, the BSE Sensex on Friday bounced back 599.34 points to close at 73088.33 on expectation of minimal escalation of tension between Israel and Iran.

see more..

19 Apr 2024 | 5:24 PM

Mumbai, Apr 19 (UNI) IT major Wipro on Friday reported 7.80% year-on-year dip in consolidated net profit at Rs 2,834.6 crore for January-March quarter (Q4) of the financial year 2023-24.

see more..
Rupee up 8 paise against USD

Rupee up 8 paise against USD

19 Apr 2024 | 5:05 PM

Mumbai, April 19 (UNI) The Rupee on Friday ended positive at 83.47, rising 8 paise against the USD on selling US Dollar by bankers and exporters, dealers at the Foreign exchange said.

see more..
image